Evidence map›Paper›PMID 42671146›Full record

ArticleGenes, chromosomes & cancer2026

Malignant MITF-Rearranged PEComa With Novel EEF1A1::MITF Fusion.

Sierra Raney, Arivarasan Karunamurthy, Jonhan Ho, Robert Bubar, Maedeh Mohebnasab, John Skaugen, Mohamed Elmoryah, Benjamin Nacev, Richard McGough, Ivy John

Abstract readCase Reports
In one paragraph

Article in Genes, chromosomes & cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sierra RaneyDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0009-0001-8896-2970
Arivarasan KarunamurthyDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jonhan HoDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Robert BubarDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-0121-4636
Maedeh MohebnasabDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-6623-9514
John SkaugenDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-6244-9693
Mohamed ElmoryahDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-8822-2588
Benjamin NacevDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-4991-2492
Richard McGoughDepartment of Orthopaedic Surgery, University of Pittsburgh, Pennsylvania, USA.
Ivy JohnDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-4751-7678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MITF-rearranged PEComas are rare, and their relationship to MITF-altered melanocytic tumors remains incompletely characterized. We report a malignant superficial soft tissue neoplasm of the thigh in a 45-year-old woman harboring a novel EEF1A1::MITF fusion. The tumor was composed of epithelioid to plump spindle cells arranged in sheets, nests, and short fascicles with prominent capillary vasculature. Significant cytologic atypia, brisk mitotic activity, and necrosis were present. The tumor cells showed diffuse strong nuclear MITF and diffuse GPNMB expression, with patchy SMA, scattered desmin, and multifocal cathepsin K positivity, while S100, SOX10, HMB45, Melan A, PRAME, tyrosinase, pancytokeratin, CD34, and TFE3 were negative. Although atypical for classic PEComa, this immunophenotype resembles that described in MITF-overexpressing PEComas. Molecular studies identified an ATRX frameshift mutation, homozygous CDKN2A/CDKN2B deletion, complex copy number alterations, and an in-frame EEF1A1::MITF fusion. No canonical TSC1, TSC2, or FLCN alteration was identified. These findings expand the molecular spectrum of PEComa and support the emerging concept that a subset of cutaneous PEComas may be driven by MITF rearrangements.

Indexed as

Microphthalmia-Associated Transcription FactorOncogene Proteins, FusionPeptide Elongation Factor 1Perivascular Epithelioid Cell NeoplasmsFemaleGene RearrangementHumansMiddle AgedEEF1A1 protein, humanMicrophthalmia-Associated Transcription FactorMITF protein, humanOncogene Proteins, FusionPeptide Elongation Factor 1EEF1A1::MITFMITFMITF‐overexpressing PEComaPEComa

Identifiers

PMID42671146
PMCPMC13528251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.